Xopenex
Product Images NDC 17478-171
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 17478-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Xop06 0006 02
Xop06 0006 03
Xop06 0006 04
Xop06 0006 05
Xop06 0006 06
Xop06 0006 07
Xop06 0006 08
Xop06 0006 09
Xop06 0006 10
Xop06 0006 11
Xop06 0006 12
Xop06 0006 13
Xop06 0006 14
Xop06 0006 15
Xop06 0006 16
Xopenex is an inhalation solution containing levalbuterol hydrochloride. Each 0.5 mL sterile unit-dose vial contains 1.25 mg of levalbuterol as the hydrochloride salt in an aqueous solution. It contains no preservatives and must be diluted before use. The solution is stored at 20° to 25°C and should be discarded if the solution is not colorless. It must be administered as directed by a physician and not exceed the recommended dose. The package should be kept out of reach of children, and the pharmacist should dispense it with the patient's information detached from the package insert. Lot/Exp details are reserved for the designated area containing the product code.*
Xop06 0006 17
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.